Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., . . . Payami, H. (2017). Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome. Movement disorders, 32(5), 739-749. https://doi.org/10.1002/mds.26942
Citace podle Chicago (17th ed.)Hill‐Burns, Erin M., et al. "Parkinson's Disease and Parkinson's Disease Medications Have Distinct Signatures of the Gut Microbiome." Movement Disorders 32, no. 5 (2017): 739-749. https://doi.org/10.1002/mds.26942.
Citace podle MLA (9th ed.)Hill‐Burns, Erin M., et al. "Parkinson's Disease and Parkinson's Disease Medications Have Distinct Signatures of the Gut Microbiome." Movement Disorders, vol. 32, no. 5, 2017, pp. 739-749, https://doi.org/10.1002/mds.26942.